Oral TRT vs injections: what the evidence actually shows

What did @kmartfit actually say?

The creator drew a sharp line between two types of low testosterone and two treatment approaches. If your testosterone is just "slightly under the optimal level," oral TRT is described as a pill that will "tell your body to start producing more testosterone." If your body "is actually no longer able to produce an adequate amount," that's where injectable TRT becomes necessary. He also called injectable testosterone "bioidentical," arguing this means fewer side effects at the right dose.

He finished with a pitch: comment "TRT" and he'll share the clinic he uses, where his levels "hover around 950 to 1,000."

Does the science back this up?

Partially, but the oral TRT explanation is where things go sideways. The FDA-approved oral testosterone options currently on the market, specifically testosterone undecanoate (Jatenzo, Tlando, Kyzagenersa), are not secretagogues. They do not tell your body to make more testosterone. They deliver exogenous testosterone directly, just like injections do, absorbed through the lymphatic system to partially avoid first-pass liver metabolism.

Secretagogues, the drugs that actually signal the body to produce more testosterone, are compounds like clomiphene citrate (clomid) or enclomiphene, or peptides like kisspeptin analogs. Those are not oral testosterone. Conflating the two is a meaningful clinical error. A 2021 review by Patel et al. in Sexual Medicine Reviews specifically distinguishes exogenous testosterone therapy from testosterone stimulating agents, noting they work through entirely different mechanisms and carry different fertility implications.

What did they get wrong (or right)?

The "bioidentical" framing for injectable testosterone cypionate is mostly accurate in common usage. Testosterone cypionate delivers the same testosterone molecule your body produces, esterified for slower release. The claim that proper dosing avoids "crazy side effects" is a reasonable generalization, though it glosses over real risks including erythrocytosis, testicular atrophy, and suppressed fertility that apply regardless of delivery method. Wang et al. (2004, Journal of Clinical Endocrinology and Metabolism) documented these consistently across injectable protocols.

The binary framing of low testosterone as either "slightly under optimal" or "no longer able to produce adequate amounts" is an oversimplification. Hypogonadism has a spectrum, and the distinction between primary, secondary, and mixed hypogonadism matters clinically far more than a vague severity threshold. The creator is not wrong that different patients suit different treatments. He is wrong about what oral TRT mechanically does.

What should you actually know?

Here is the practical breakdown if you are evaluating TRT options:

• FDA-approved oral testosterone (undecanoate) is exogenous testosterone, not a stimulant that boosts your own production. It suppresses your natural testosterone production the same way injections do.
• If preserving fertility or natural production matters to you, the drugs you want to ask about are clomiphene, enclomiphene, or human chorionic gonadotropin (hCG), none of which are oral testosterone.
• Injectable testosterone cypionate or enanthate remains the most studied, cost-effective, and pharmacologically predictable option for diagnosed hypogonadism. A 2018 systematic review by Corona et al. in Expert Opinion on Pharmacotherapy confirmed long-term safety data is strongest for intramuscular formulations.
• "Optimizing" testosterone to levels of 950 to 1,000 ng/dL is not standard medical practice for hypogonadism treatment, which targets restoring levels to the mid-normal range, roughly 400 to 700 ng/dL depending on the guideline. Higher targets are used in some clinical contexts but carry tradeoffs worth discussing with a physician.
• Any clinic or creator promising optimization without a thorough workup, including LH, FSH, and a diagnosis of the hypogonadism type, is skipping steps that matter.

Bottom line

The creator is clearly knowledgeable about his own experience with injectable TRT and gives reasonable practical context about finding a willing prescriber. But the core claim that oral TRT "tells your body to produce more testosterone" is factually incorrect based on how FDA-approved oral testosterone products actually work. That distinction is not semantic. It affects who should use what, and why.